Delivery Order SPE2DB24D9315-SPE2DB24FFWHL

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $1,092.04 for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,092.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025....
This $5,674.40 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML medical supplies, with a period of performance through September 10, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.04 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, with a performance period through August 12, 2024. The award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $3,298.11 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract valued up to $4,999,999 that enables the DLA to place orders for a wide range of pharmaceutical products to support military health facilities worldwide. Under this contract, DMS Pharmaceutical Group will provide...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,269.76 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 31, 2024, with an ultimate completion date of August 1, 2024. The contract is for the delivery of 4565399768 - TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC)...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,628 contract is for the delivery of meningococcal group vaccines and medical supplies, with a period of performance through June 2025. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $28,076.00, is a firm fixed-price delivery order for BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The award is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,136.56 for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. It is a firm fixed-price contract with an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,022.00 firm fixed-price delivery order is for the supply of 4568292980 BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through May 14, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9315
    Indefinite Delivery Contract
  • SPE2DB24D9315-SPE2DB24FFWHL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,092.04 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, with a period of performance through September 5, 2024.

DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 12/4/24, 9:15 AM